The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Mit dem Deal entsteht ein riesiger Konzern für Gesundheits- und Pflegeprodukte. Kimberly-Clark bezahlt einen deutlichen Aufpreis gegenüber dem Aktienkurs von Kenvue.

Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue for $48.7 billion.

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America

Kimberly-Clark se hace con Kenvue, con marcas como Johnson’s o Listerine, una empresa a la que Trump acusa de vender un analgésico relacionado con el autismo

The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.